A tracheostomy itself does not directly reduce life expectancy. The procedure is typically performed to save or extend life, not shorten it. What does affect survival is the underlying condition that made the tracheostomy necessary in the first place. A person who needs a tracheostomy after severe trauma faces a very different outlook than someone who receives one for a progressive neurological disease. The tube in the airway is a tool, and the prognosis depends heavily on what that tool is helping manage.
What Survival Rates Actually Look Like
Survival statistics for tracheostomy patients vary widely because the populations studied are so different. In critically ill adults, mortality within 30 days of the procedure runs around 12%, based on a study of 238 patients with ventilator-dependent respiratory failure. That number reflects the severity of the illness, not the risk of the procedure itself. In-hospital mortality after tracheostomy has been reported as high as 22% in some analyses, again driven by the critical conditions that prompted surgery.
Among children who depend on a tracheostomy long-term, about 83% survive to one year and 68% survive to five years. The first year carries the most risk: survival drops roughly 10% between six months and one year after placement. Children whose tracheostomy was placed for lung-related reasons had a shorter time to death compared to those who received one for airway obstruction or neurological conditions, even though overall mortality rates across those groups were statistically similar.
For critically ill adults tracked over a full year in an Italian multi-center study, mortality climbed progressively from ICU discharge through 12 months, reaching as high as 71% at one year. These were among the sickest patients in the hospital system. The trajectory reinforces the point: the underlying illness, not the tracheostomy, is the primary driver of survival.
The Underlying Condition Matters Most
The single biggest factor in life expectancy after a tracheostomy is why you needed one. Cardiac disease triples the odds of dying during a hospitalization for tracheostomy complications. Liver disease more than doubles the risk. Neurological diseases and trauma each roughly double mortality risk as well. In non-elderly patients, conditions like metastatic cancer and blood clotting disorders are significant predictors of death. In elderly patients, fluid and electrolyte imbalances stand out as the strongest predictor.
Age plays a role too, though its effect is modest compared to comorbidities. Each additional year of age slightly increases mortality risk. Longer hospital stays are also associated with worse outcomes, likely because they reflect more complicated or severe illness rather than being harmful on their own.
How a Tracheostomy Can Extend Life
In many cases, a tracheostomy is what keeps a person alive. Patients on mechanical ventilation often wean faster once a tracheostomy replaces an endotracheal tube (the tube placed through the mouth). The reasons are practical: a tracheostomy allows better removal of lung secretions, reduces damage to the voice box, improves oral hygiene, and in many cases lets the patient eat and speak. These benefits compound over time. Better secretion clearance means fewer lung infections. The ability to eat means better nutrition and strength for recovery.
For people with ALS, a tracheostomy connected to a ventilator can add years of life. Without invasive ventilation, ALS is typically fatal within three to five years of diagnosis. One study found that the average survival after tracheostomy in ALS patients was about 253 days, though a Korean survey of long-term tracheostomy users reported an average care duration of nearly six years, with patients living an average of three years after tracheostomy placement. The difference likely reflects variations in care quality and patient selection.
Complications That Can Affect Outcomes
Tracheostomy-related complications occur in roughly 10% to 45% of cases depending on how broadly complications are defined and how long patients are followed. In one study at a single tertiary care center, 10% of patients experienced at least one complication within 90 days of placement. While that rate is relatively low, the complications tend to be severe when they happen.
Short-term risks include bleeding, infection, and, rarely, death directly from the procedure. Three patients in that same study died from complications, all within three days of placement. Longer-term complications include narrowing of the airway (tracheal stenosis), softening of the tracheal cartilage, and abnormal connections between the trachea and esophagus. Patients whose tracheostomy is placed later in their hospital course (after nine or more days) face higher rates of complications like blood clots, pneumonia, and lung injury.
Decannulation and Its Impact
Decannulation, the removal of the tracheostomy tube once it is no longer needed, is a strong positive sign. A large analysis of over 5,300 patients found that about 53% were decannulated before hospital discharge, and these patients had higher survival rates than those who kept their tubes. Getting the tube out signals that the underlying condition has improved enough for the patient to breathe independently.
Not everyone reaches that point. Among children with neurological conditions requiring a tracheostomy, only about 15% were decannulated after 5.5 years of follow-up. The probability of decannulation drops significantly after five years, which is important information for families weighing the long-term outlook. For children overall, the median time to decannulation was about two years.
Where You Recover Makes a Difference
Patients with tracheostomies are significantly less likely to go home after leaving the ICU compared to patients without them. At three months post-discharge, only about 58% of tracheostomy patients were home. The rest were split between hospital facilities and rehabilitation centers. By 12 months, 84% had made it home, but the slow transition reflects the complexity of tracheostomy care.
This matters for survival because care outside of specialized settings can be suboptimal. Patients discharged from the ICU to general hospital wards or rehabilitation facilities face higher mortality risk, partly because staff may be less experienced with tracheostomy management. Proper suctioning, tube changes, and monitoring for complications require specific training. For patients going home, having trained caregivers and reliable access to medical supplies directly influences long-term outcomes.
Pediatric Considerations
Children with tracheostomies face a mortality rate between 13% and 27%, depending on the study and population. The higher end of that range comes from centers treating more complex cases. The first year after tracheostomy is the highest-risk period for children, just as it is for adults. Children with seizure disorders have significantly higher mortality than those without, regardless of why the tracheostomy was placed.
Pulmonary conditions carry the worst prognosis among pediatric tracheostomy patients: nearly half of deaths in one study occurred in this group. Neurological conditions, while associated with lower decannulation rates, did not carry significantly higher mortality overall. For families considering a tracheostomy for a child, the realistic conversation centers on the child’s underlying diagnoses and their trajectory, not on the tracheostomy as an independent risk factor.